Wharton Business Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-11,907
| Closed | -$395K | – | 139 |
|
2023
Q3 | $395K | Hold |
11,907
| – | – | 0.02% | 106 |
|
2023
Q2 | $437K | Hold |
11,907
| – | – | 0.03% | 94 |
|
2023
Q1 | $485K | Hold |
11,907
| – | – | 0.03% | 92 |
|
2022
Q4 | $610K | Hold |
11,907
| – | – | 0.04% | 86 |
|
2022
Q3 | $521K | Hold |
11,907
| – | – | 0.04% | 82 |
|
2022
Q2 | $624K | Hold |
11,907
| – | – | 0.04% | 79 |
|
2022
Q1 | $616K | Hold |
11,907
| – | – | 0.04% | 77 |
|
2021
Q4 | $703K | Buy |
+11,907
| New | +$703K | 0.04% | 76 |
|
2021
Q3 | – | Sell |
-11,907
| Closed | -$466K | – | 115 |
|
2021
Q2 | $466K | Hold |
11,907
| – | – | 0.04% | 82 |
|
2021
Q1 | $431K | Buy |
11,907
+146
| +1% | +$5.29K | 0.03% | 84 |
|
2020
Q4 | $433K | Sell |
11,761
-41
| -0.3% | -$1.51K | 0.04% | 80 |
|
2020
Q3 | $411K | Buy |
11,802
+2,041
| +21% | +$71.1K | 0.04% | 77 |
|
2020
Q2 | $303K | Sell |
9,761
-48
| -0.5% | -$1.49K | 0.03% | 89 |
|
2020
Q1 | $304K | Sell |
9,809
-1,080
| -10% | -$33.5K | 0.03% | 72 |
|
2019
Q4 | $405K | Hold |
10,889
| – | – | 0.04% | 76 |
|
2019
Q3 | $371K | Hold |
10,889
| – | – | 0.04% | 74 |
|
2019
Q2 | $448K | Hold |
10,889
| – | – | 0.05% | 69 |
|
2019
Q1 | $439K | Sell |
10,889
-72
| -0.7% | -$2.9K | 0.05% | 73 |
|
2018
Q4 | $454K | Hold |
10,961
| – | – | 0.05% | 69 |
|
2018
Q3 | $458K | Sell |
10,961
-97
| -0.9% | -$4.05K | 0.05% | 69 |
|
2018
Q2 | $380K | Buy |
11,058
+347
| +3% | +$11.9K | 0.04% | 78 |
|
2018
Q1 | $361K | Buy |
10,711
+97
| +0.9% | +$3.27K | 0.04% | 76 |
|
2017
Q4 | $365K | Hold |
10,614
| – | – | 0.04% | 81 |
|
2017
Q3 | $359K | Buy |
10,614
+1,025
| +11% | +$34.7K | 0.04% | 84 |
|
2017
Q2 | $306K | Buy |
9,589
+103
| +1% | +$3.29K | 0.03% | 93 |
|
2017
Q1 | $308K | Buy |
+9,486
| New | +$308K | 0.03% | 95 |
|